MARK2-C11ORF84 Fusion FISH Probe
The MARK2-C11ORF84 Fusion FISH Probe is used to confirm a fusion of the MARK2 and C11ORF84 genes. The fusion of the MARK2 and C11ORF84 genes has been associated with Uterine Corpus Endometrial Carcinoma, Head And Neck Squamous Cell Carcinoma , and Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MARK2-C11ORF84-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MARK2-C11ORF84-20-AQAQ | 20 (40 μL) | 200 μL |
|
MARK2 Gene Summary
This gene encodes a member of the Par-1 family of serine/threonine protein kinases. The protein is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2009]
Gene Name: Microtubule Affinity Regulating Kinase 2
Chromosome: CHR11: 63606399 -63678492
Locus: 11q13.1
C11orf84 Gene Summary
The Chromosome 11 Open Reading Frame 84 (C11orf84) gene is located on chr11 :63580922-63595190 at 11q13.1.
Gene Name: Chromosome 11 Open Reading Frame 84
Chromosome: CHR11: 63580922 -63595190
Locus: 11q13.1
Gene Diseases
The MARK2 C11ORF84 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
| Head And Neck Squamous Cell Carcinoma |
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|